H
Hiroshi Komatsu
Researcher at Kyoto Prefectural University of Medicine
Publications - 48
Citations - 473
Hiroshi Komatsu is an academic researcher from Kyoto Prefectural University of Medicine. The author has contributed to research in topics: Medicine & Schizophrenia (object-oriented programming). The author has an hindex of 10, co-authored 27 publications receiving 380 citations.
Papers
More filters
Journal ArticleDOI
Outbreak of severe neurologic involvement associated with enterovirus 71 infection
TL;DR: Enterovirus 71 is one of the pathogenic viruses that cause hand-foot-and-mouth syndrome, as well as a variety of other clinical manifestations, the most important of these is neurologic disease, especially in infants and young children.
Journal ArticleDOI
Mycoplasma pneumoniae meningoencephalitis and cerebellitis with antiganglioside antibodies.
TL;DR: The hypothesis that vasculopathy and demyelination caused by an immunologic mechanism play an important role in the pathogeneses of neurologic disorders associated with M. pneumoniae infection is supported.
Journal ArticleDOI
The Pharmacological Characteristics of Molecular-Based Inherited Salt-Losing Tubulopathies
Kandai Nozu,Kazumoto Iijima,Kyoko Kanda,Koichi Nakanishi,Norishige Yoshikawa,Kenichi Satomura,Hiroshi Kaito,Yuya Hashimura,Takeshi Ninchoji,Hiroshi Komatsu,Koichi Kamei,Ritsuko Miyashita,Masaaki Kugo,Hiroshi Ohashi,Hajime Yamazaki,Hiroyo Mabe,Asa Otsubo,Takashi Igarashi,Masafumi Matsuo +18 more
TL;DR: This study revealed the following characteristics of these disorders: subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome, and subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.
Journal ArticleDOI
Acute cerebellar ataxia with human parvovirus B19 infection
TL;DR: A 2 year old boy developed acute cerebellar ataxia in association with erythema infectiosum and genomic DNA and antibodies against human parvovirus B19 were detected in serum but not in cerebrospinal fluid.
Journal ArticleDOI
Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy.
Yoshihiro Takeuchi,Yuri Miyanomae,Hiroshi Komatsu,Yoshikazu Oomizono,Akira Nishimura,Sozo Okano,Tetuo Nishiki,Tadashi Sawada +7 more
TL;DR: Thyrotropin-releasing hormone has a neurotrophic effect on the spinal anterior motor neurons of spinal muscular atrophy patients and thus may be warranted for the management of spinal muscles atrophy.